<DOC>
	<DOCNO>NCT02284269</DOCNO>
	<brief_summary>The purpose study integrate post-marketing surveillance data ( Specified use-results survey long-term treatment ) 6 SGLT2 inhibitor approve applied Japan evaluate safety efficacy long-term use actual clinical practice condition . In post-marketing surveillance , 3000 patient complete 3 year treatment enrol . A total 18000 patient assessed meta-analysis .</brief_summary>
	<brief_title>Meta-analysis Post-marketing Surveillances SGLT2 Inhibitors Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Patients Type 2 diabetes mellitus start medication SGLT2 inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>